SEVERE GYNECOMASTIA IN AN AFRICAN BOY WITH PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS INFECTION RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
Authors:
- Margaret ClapsonMCMargaret Clapson
- Simon WitheySWSimon Withey
- Alan BatesABAlan Bates
- Vas NovelliVNVas Novelli
- 1 February 2006
- journal article
- case report
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 25 (2) , 183-184
Abstract
Highly active antiretroviral therapy (HAART) slows the progression of human immunodeficiency virus (HIV) disease and lowers mortality and morbidity in children. Coincident with these advances, an increasing number of side effects are being reported. We describe an adolescent boy with perinatally acquired HIV infection who developed significant bilateral breast enlargement as a result of HAART. He required bilateral mastectomies. Pediatricians need to be aware of less common side effects of HAART.Keywords
This publication has 10 references indexed in Scilit:
- Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in EuropeAIDS, 2004
- True Gynecomastia in Congenitally HIV-Infected Children Treated with Antiretroviral AgentsJournal of Chemotherapy, 2004
- Efavirenz-Associated Gynecomastia: Report of Five Cases and Review of the LiteratureThe Breast Journal, 2004
- Gynaecomastia in HIV-Infected Men on Highly Active Antiretroviral Therapy: Association with Efavirenz and Didanosine TreatmentAntiviral Therapy, 2004
- Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandBMJ, 2003
- Breast Enlargement in 13 Men Who Were Seropositive for Human Immunodeficiency VirusClinical Infectious Diseases, 2002
- Pathology of the Breast Associated With HIV/AIDSThe Breast Journal, 2002
- Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the LiteratureClinical Infectious Diseases, 2001
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998